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Summary 
Xanthines represent a new, versatile scaffold for combinatorial chemistry. A five-step solid-phase 
synthesis of xanthine derivatives i described which includes alkylations, a nucleophilic displacement 
reaction at a heterocycle and a ring closure reaction by condensation of a nitroso function with an 
activated methylene group. The selected reaction sequence allows the production of a highly diverse 
small-molecule combinatorial compound library. 
Introduction 
Combinatorial compound libraries represent a powerful 
method to identify new pharmaceutical lead compounds 
for a given biological target [1]. One of the challenges in 
generating new kinds of libraries is the development of 
scaffolds that allow the introduction of a maximum of 
diversity. Recent investigations howed the successful 
synthesis on a solid support of several small molecules 
that are suitable as scaffolds for the generation of molec- 
ular diversity [2]. The application of solid-phase technol- 
ogy to the preparation of such new scaffolds for combina- 
torial chemistry requires the transfer of solution-phase 
chemistry to conditions that are feasible on the solid 
support. The reactions hould proceed in resin-swelling 
solvents and the reaction temperatures should be kept at 
reasonable values. 
Xanthines represent a new structurally rigid scaffold 
for combinatorial chemistry. Certain naturally occurring 
xanthines (e.g. caffeine, theophylline and theobromine) 
are well known to exert prominent physiological effects at 
very low doses, and they have been used as pharmaceuti- 
cals, narcotics or stimulants for many centuries [3]. To- 
day, 8-substituted xanthines are studied extensively for 
clinical application [4], as they inhibit many pharmacolog- 
ical and physiological effects of adenosine [5]. In order to 
use the xanthine scaffold for combinatorial chemistry, we 
have developed a method of solid-phase synthesis of 
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highly substitutable xanthines for the generation of new 
compound libraries. 
Results and Discussion 
The ring closure reaction of 1,3-dialkyl-6-alkylamino-5- 
nitrosouracils 1 proceeds easily, giving the corresponding 
xanthine derivatives 2, as long as N1 is blocked by a 
substituent (Scheme 1) [6]. 
The application of solid-phase technology to the gener- 
ation of combinatorial compound libraries necessitates the 
adaptation of this reaction to solid-phase conditions. As 
a first step, we coupled bromoacetic acid to the free amino 
function of a solid support 3, which is modified by the 
Rink amide linker [7]. We used the Rink linker because 
of its stability towards a wide variety of reaction condi- 
tions. 1-Alkyl-4-chlorouracils 5 were then attached to the 
solid phase by alkylation of the nitrogen at the uracil 
system to form intermediates 6. The chlorine of the resin- 
bound uracils 6 can easily be replaced by primary benzyl- 
amines to form 4-benzylaminouracils 7. 
The intermediates 7, bound to the solid support, were 
treated with isopentyl nitrite in the presence of a small 
amount of acetic acid. The nitroso compounds formed 
first immediately undergo ring closure to form the xan- 
thine derivatives 8. This conversion could be followed by 
UV spectroscopy, since the absorption band at 260 265 
nm, characteristic for the uracil-type compounds 7, disap- 
172 
O O 
R H RI~N~NO I~N~-... jN 
; 
I H R3 I 
R2 R2 
1 2 
Scheme 1. Formation of xanthine derivatives 2 by ring closure of 1,3-dialkyl-6-alkylamino-5-nitrosouracils 1. Note that N1 is blocked. 
peared and was shifted to 306-310 nm, characteristic for 
xanthines 8. The progress of all reactions was judged by 
cleavage of a small amount of the reaction product from 
the solid phase, followed by analysis by UV spectroscopy 
and comparison of HPLC characteristics of the product 
with those of product prepared in solution (if available). 
Alkylation of these compounds proceeded with excess 
alkylating agent in the presence of triethylamine to give 
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Fig. 1. Solid-phase synthesis of fully substituted xanthines. 
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TABLE 1 
ANALYTICAL DATA OF SYNTHESIZED XANTHINE DERIVATIVES 
R~N~N,  
I R4 
R2 
No. R~ R 2 R 3 R 4 Yield a (mg) Retention time MW (g/mol) 
(min) (see text) MS (MH+) b 
10a CH 3 ~/NH2 ~ ~  2'-OCH 3 1.94 (10%) 10.87 367.37 
" 1 
368.1 
O 
10b ~ ~/ .NH2 ~/ .NH2 4'-CF3 3.63(14%) 13.06 500.44 
L j/ -1  -1  502.2 O O 
10e CH 3 ~/NH2 H 4'-F 1.80 (19%) 8.75 317.28 
" 1 
320.4 
O 
10d CH 3 ~/NHz ~/NH2 4'-F 3.55 (32%) 6.57 374.33 
" 1 " 1 
377.2 
O O 
10e CH 3 ~/NH2 H 4'-CH 3 2.34 (25%) 9.45 313.32 c 
" 1 
314.5 
O 
10f CH 3 /~,~NH2 ,./~NH2 4'-CH 3 3.56(32%) 7.46 371.4 0"37~ 
O O 
10g CH2CH2CH 3 ~/NH2 H 4'-F 2.42 (23%) 10.60 345.33 
" 1 
344.1 
O 
10h CH2CH2CH , ~/NH2 ~/NH2 4'-F 3.10(26%) 8.20 402.38 
" 1 " 1 
403.6 
O O 
10i CH2CH2CH 3 ~/NH2 H 4'-CH 3 1.31 (13%) 11.23 341.37 
" 1 342.4 
O 
10j CH2CH2CH 3 ~/NH~ ~/NH2 4'-CH 3 1.52 (11%) 8.98 398.42 
" 1 " I 
400.5 
O O 
a The yield after RP-HPLC purification (based on a resin loading of 0.23 mmol/g) reflects the recovery of pure product. Analysis by RP-HPLC 
of the crude products (after cleavage from the resin) showed purities indicated by peak areas ranging from 86-98% (X = 300 nm) of 65-89% (X = 
220 nm). 
b Mass spectrometric data were obtained on a MALDI system (Linear Scientific 1700, Reno, CA, U.S.A.). 
For NMR data see text. 
the fully substituted xanthines 9. The final products 10 
were cleaved from the solid support  by the action of  
tr i f luoroacetic acid. The cleavage procedure was as fol- 
lows. The resin was treated twice with 95% tri f luoroacetic 
acid and washed with 95% tr i f luoroacetic acid, dichloro- 
methane and tr i f luoroethanol.  The combined solvents 
were removed over potass ium hydroxide in an evacuated 
desiccator, after which the residues were lyophil ized twice 
f rom dilute acetic acid and directly purif ied by HPLC.  
Analyt ical  and preparat ive HPLC was per fo rmed on a 
Jasco system (Tokyo, Japan). Analyt ical  runs were carr ied 
out  on a Waters Symmetry  C18 co lumn (3.9 x 150 mm)  
using a l inear solvent gradient f rom 5% to 100% solvent 
B in 20 min (solvent A = 0.1% TFA in water; so lvent  B = 
0.1% TFA in acetonitri le/water, 7:3). Preparat ive runs 
were carr ied out  on a Waters Symmetry  C18 co lumn (19 
x 150 mm) with a l inear solvent gradient f rom 25% to 
60% solvent B in 22 min. 
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We investigated the applicability of this method by 
first synthesizing two individual xanthines (10a and 10b). 
The potential of the synthetic scheme to produce combi- 
natorial compound libraries was then determined by the 
synthesis of a group of eight related xanthines (10e-10j). 
The original amount of resin was continuously divided 
into smaller portions along with the progressing reaction 
sequence (see Fig. 1). In this way, eight individual xan- 
thines were obtained by cleavage from the eight different 
resin portions. The analytical data of these compounds 
are summarized in Table 1. The structure of two com- 
pounds (10e and 10f) was verified by NMR spectroscopy. 
NMR spectra were recorded on a Bruker 300 MHz in- 
strument. NMR data of compound 10e: ~H NMR 
(DMSO-d6, ppm): 7.53 d (2H), 7.36 d (2H) ArH; 4.58 s 
(2H) CH2CO; 3.30 s (3H) N-CH3; 2.38 s (3H)p-CH 3. 
NMR data of compound 10f: IH NMR (DMSO-d6, ppm): 
7.67 d (2H) CO-NH2; 7.53 d (2H), 7.36 d (2H) ArH; 7.28 
d (2H) CO-NH2; 4.94 s (2H) CH2CO; 4.57 s (2H) 
CH2CO; 3.28 s (3H) N-CH3; 2.38 s (3H)p-CU 3. 
Conclusions 
We have demonstrated the successful transfer of sol- 
ution-phase reactions to a solid-phase synthesis of xan- 
thine derivatives. The applicability of this synthetic strat- 
egy for the generation of molecular diversity was tested 
with the preparation of a small xanthine library consisting 
of eight individual entities. The method can easily be ex- 
tended to generate libraries with a large number of com- 
pounds. A library containing 90 individual compounds 
was prepared in this way and is currently being tested in 
various biological assays. 
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